lung-cancer

Documents about lung-cancer

• Organotin(IV) Dithiocarbamate Compounds Targeting A549 Lung Cancer Cells via Mitochondria-Mediated Apoptosis#135556Unpaywall
• Examining implementation strategies to reduce disparities in lung cancer screening uptake by state Medicaid expansion status: a scoping review.#138589NCBI PubMed Central
• Radiation-induced esophagitis and lung injury during esophageal squamous cell cancer therapy is correlated to tumor gene expression phenotype.#152200NCBI PubMed Central
• Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 study#157665HAL (France)
• Camrelizumab With AC in Patients With Brain Metastases of Driven Gene-negative,NSCLC#158214ClinicalTrials.gov
• Quantitative peri-lesional densitometry mapping via thin-slice volume rendering enhances differentiation of pneumonic-type lung cancer and inflammatory pneumonia.#182527NCBI PubMed Central
• Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial#208802HAL (France)
• A Study of the Correlation of Perfusion Parameters in High-Resolution GRASP MRI With Microvascular Density in Lung Cancer.#214236NCBI PubMed Central
• Causal effects of plasma protein-protein ratios on lung cancer subtypes: A proteome-wide Mendelian randomization and mediation analysis.#227852NCBI PubMed Central
• Beyond the Scan: Adapting Multimodal Lung Cancer Screening for Central and Eastern Europe-Overcoming Systemic Barriers and Epidemiological Confounders.#236028NCBI PubMed Central
• Unveiling the cognitive fog in lung cancer patients: non-invasive exploration of blood-brain barrier disruption and brain structural changes.#308753NCBI PubMed Central
• Multi-Task and Federated Learning for Breast and Lung Cancer Screening and Diagnosis: A Survey and Future Research Directions.#315461NCBI PubMed Central
• Real-World Impact of Electronic Patient-Reported Outcomes on Early Intervention Among Older Patients With Lung Cancer: Prospective Cohort Study.#351708NCBI PubMed Central
• Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies#379000Open Research
• Serum carotenoids and mortality from lung cancer : a case-control study nested in the Japan Collaborative Cohort (JACC) Study#384144CiNii
• Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC#394755ClinicalTrials.gov
• Tobacco Use, Stigma, and Coping in Lung Cancer: A Systematic Review of Their Psychosocial Interactions and Clinical Implications.#409067NCBI PubMed Central
• From cytology to systems pathology: Decoding the molecular heterogeneity of resectable non-small-cell lung cancer#411898IRIS
• KRAS-Specific Autologous TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors#414486ClinicalTrials.gov
• Prognostic impact of stage reclassification and N2 subclassification in the ninth edition of TNM classification for non-metastatic lung cancer#417303AVESIS
• Use and impact of risk-based eligibility models in low-dose computed tomography lung cancer screening: a systematic review.#427684NCBI PubMed Central
• Geographic Access to Low-Dose CT Lung Cancer Screening in Tennessee: Disparities by Socioeconomic Variables, Rurality, and Appalachian Status.#440891NCBI PubMed Central
• Evaluation of zongertinib for the treatment of metastatic non-squamous non-small cell lung cancer with <i>HER2</i> TKD activating mutation#287783Figshare
• Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT)#146457ClinicalTrials.gov
• Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study#11468HAL (France)
• Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU Program#152394ClinicalTrials.gov
• Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancer#153533HAL (France)
• A Noddings' caring theory-based intervention to enhance coping with death competence in advanced lung cancer patients: a randomized controlled trial.#170491NCBI PubMed Central
• Deep learning-based feature selection for lung adenocarcinoma classification and biomarker discovery#177838Zenodo (CERN)
• Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors#180214ClinicalTrials.gov
• Methyleugenol Enhances the Anticancer Effect of Chemotherapeutic Drug and Boosts Chemotherapy Drug Tolerance#194491Indonesian Journal of Pharmacy
• Generative AI‐Driven CNN Framework for Enhanced Lung Cancer Detection, Prediction, and Treatment: A Novel Approach to Overcoming AI Limitations.#219131NCBI PubMed Central
• Quantum dot-DNA microsphere aptamer biosensor with AI-assisted structural modeling for rapid detection of the lung cancer biomarker USE1.#227805NCBI PubMed Central
• Mixed-Method Formative Evaluation and Cultural Adaptation of Digital Health Communication Content and Delivery Promoting Lung Cancer Screening Shared Decision-Making.#242309NCBI PubMed Central
• SHR0302 Combined With PD-1/PD-L1 Inhibition for Treatment naïve or Acquired Resistant to Immunology NSCLC#245495ClinicalTrials.gov
• Immune network remodeling driven by ferroptosis: Bidirectional interaction mechanisms among multiple immune cells in the lung cancer immune microenvironment (Review).#265487NCBI PubMed Central
• Pathological response and tumor regression grading following neoadjuvant chemo-immunotherapy and chemotherapy in resectable non-small cell lung cancer.#269552NCBI PubMed Central
• Beyond the primary site: Molecular insights and clinical implications of cancer metastatic overlap between lung and urological organ cancers (Review).#275479NCBI PubMed Central
• A Study to Evaluate the Efficacy and Safety of Anti-PD-1 Antibody AK105 in Patients With Selected Advanced Solid Tumors#303748ClinicalTrials.gov
• Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer#311126ClinicalTrials.gov
• Prognostic value of post-induction chemotherapy 18F-FDG PET-CT in stage II/III non-small cell lung cancer before (chemo-) radiation#312111HAL (France)
• From conversation to completion: identifying conversation elements to support effective shared decision-making for lung cancer screening in rural primary care.#354788NCBI PubMed Central
• A novel micelleplex for tumour-targeted delivery of CRISPR-Cas9 against KRAS-mutated lung cancer#365099Open Access LMU
• A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC#435737ClinicalTrials.gov
• Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA)#444864ClinicalTrials.gov
• Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC#444878ClinicalTrials.gov
• An in vitro analysis of brassica oleracea L. var. capitata f. rubra extract coupled with sonodynamic therapy (SDT) on H69PR lung cancer cell lines#366126Animo Repository
• RAPA-201 Therapy of Solid Tumors#426773ClinicalTrials.gov
• Sing-a-Lung 2.0: protocol for a multicentre randomised controlled trial to investigate the effects and mechanisms of online-delivered singing training versus usual care 6-18 months after surgical resection for non-small cell lung cancer (NSCLC).#368331NCBI PubMed Central
• Determinants of the Public’s Behavioral Intention to Adopt AI-Assisted Lung Cancer Screening: An Extended UTAUT Model Integrating Trust and Risk.#9155NCBI PubMed Central